Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy - Scheele, Wim; Diamond, Susan; Gale, Jeremy; Clerin, Valerie; Tamimi, Nihad; Le, Vu; Walley, Rosalind; Grover-Páez, Fernando; Perros-Huguet, Christelle; Rolph, Timothy; El Nahas, Meguid (Journal of the American Society of Nephrology, 2016)
Keywords: Adult; Aged; Aged, 80 and over; Albuminuria - drug therapy; Albuminuria - enzymology; Albuminuria - etiology; Clinical Research; Diabetic Nephropathies - complications; Double-Blind Method; Female; Heterocyclic Compounds, 2-Ring - therapeutic use; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors - therapeutic use; Sulfonamides - therapeutic use; albuminuria; nitric oxide; randomized controlled trials; diabetic nephropathy